83 related articles for article (PubMed ID: 610551)
1. The radioiodine ablatio doses. Different aspects on patients with and without functioning metastases at the time of ablation.
Belfer AJ; Van Gilse HA; Cox PH
Ann Radiol (Paris); 1977; 20(8):787-9. PubMed ID: 610551
[No Abstract] [Full Text] [Related]
2. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
3. [Radiation therapy of remote metastases from thyroid cancer].
Kiseleva ES; Falileeva EP
Med Radiol (Mosk); 1971 Feb; 16(2):27-37. PubMed ID: 5173489
[No Abstract] [Full Text] [Related]
4. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
5. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.
Maxon HR; Thomas SR; Hertzberg VS; Kereiakes JG; Chen IW; Sperling MI; Saenger EL
N Engl J Med; 1983 Oct; 309(16):937-41. PubMed ID: 6621620
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy in differentiated thyroid carcinoma.
Salvatori M; Rufini V; Garganese MC; Di Giuda D
Rays; 2000; 25(2):221-38. PubMed ID: 11370540
[TBL] [Abstract][Full Text] [Related]
7. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma.
Van Nostrand D; Atkins F; Yeganeh F; Acio E; Bursaw R; Wartofsky L
Thyroid; 2002 Feb; 12(2):121-34. PubMed ID: 11916281
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
[TBL] [Abstract][Full Text] [Related]
9. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
[TBL] [Abstract][Full Text] [Related]
10. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.
Beierwaltes WH; Rabbani R; Dmuchowski C; Lloyd RV; Eyre P; Mallette S
J Nucl Med; 1984 Dec; 25(12):1287-93. PubMed ID: 6502251
[TBL] [Abstract][Full Text] [Related]
11. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
13. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
[TBL] [Abstract][Full Text] [Related]
14. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma.
Bal C; Padhy AK; Jana S; Pant GS; Basu AK
Cancer; 1996 Jun; 77(12):2574-80. PubMed ID: 8640708
[TBL] [Abstract][Full Text] [Related]
16. [Radioiodine therapy of differentiated thyroid cancer. 10-year results of a standardized therapy in 269 patients].
Bubeck B; Kimmig B; Hermann HJ; Berndt HR; zum Winkel K
Strahlentherapie; 1984 Oct; 160(10):594-9. PubMed ID: 6495352
[TBL] [Abstract][Full Text] [Related]
17. Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.
Wiebe V; Schneider C; Franke HD
Strahlentherapie; 1975 Jan; 149(1):55-9. PubMed ID: 1124555
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness between a single low dose and fractionated doses of radioiodine in ablation of post-operative thyroid remnants.
Hung GU; Tu ST; Wu IS; Yang KT
Jpn J Clin Oncol; 2004 Aug; 34(8):469-71. PubMed ID: 15371465
[TBL] [Abstract][Full Text] [Related]
20. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
[No Abstract] [Full Text] [Related]
[Next] [New Search]